Few randomized controlled studies, the only trial design where causality can be established between an intervention and the benefits or harms thereof, have been published on the benefits and risks of a restrictive vs a liberal transfusion strategy.
The above reported studies, the only ones present in literature on this topic to the best of our knowledge, consider the use of tamoxifen and GnRHa only in the treatment of MO.
In keeping with previous studies, the only strategy that was found that kept the purchase price of the SKYLON low enough for a viable operator business was to follow an "airline" business model where the manufacturer sells SKYLONs to other operators in addition to S-ELSO.
According to David Erritzøe, a medical doctor and post-doctoral researcher from Imperial College London, women are often skipped out of molecular imaging drugs studies – the only way to access neurotransmitter systems in the living human brain – for two grounds.
He said of portrait studies, "The only thing in painting that excites me to the depths of my soul, and which makes me feel the infinite more than anything else".
In many fMRI studies, the only acknowledgment of research ethics was a mention of informed consent – necessary, in many cases, for publication, and a frustrating confound in our attempts to identify more substantive discussion.
